By


Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp. 

– Renovacor, Inc. has entered into a de􀁾nitive merger agreement with Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) – 
– Upon closing, the combined company is expected to receive up to $116 million in proceeds and is expected to be listed on NYSE under the ticker symbol “RCOR” – 
– The business combination is expected to be completed in the second quarter of 2021 – 

See more here

By


Immunome Advances Its Proprietary Antibody Against IL-38, a Novel Innate Immune Checkpoint, into IND-enabling Studies

First oncology product candidate identified using the company’s human memory B-cell platform, and intended for potential treatment of solid tumors  

See more here

By


ArchCare Delivers PACE Participants Seamless, Free Transportation

Technology-Based Ride System Will Serve 702 Home-Based Elderly  

See more here

By


Annovis Bio Announces Positive Phase 2 Data – Interim Data Shows ANVS401 Improves Speed and Coordination in Parkinson’s Patients

See more here

By


Annovis Bio Signs GMP Manufacturing Agreement to Support Planned Late-Stage Studies

See more here

By


Venatorx Pharmaceuticals Expands Anti-Infective Portfolio with HBV Candidate 

VNRX-9945 Selected as 3rd Generation Hepatitis B Virus Orally Bioavailable CpAM; Clinical Trial Application and Phase 1 Planned for Second Quarter 2021  

See more here

By


Annovis Bio Receives Japanese Patent for the Treatment of Acute Brain or Nerve Injury

See more here

By


Melior Pharmaceuticals Receives IND Clearance from US FDA for COVID-19 Therapeutic 

  • Melior’s therapeutic candidate, tolimidone, is:  
    • Expected to mitigate the probability and severity of COVID-19 subjects developing severe lung complications 
    • A repositioned drug that has been demonstrated to be safe and well-tolerated in previous clinical studies 

See more here

By


Renowned Nutrition Expert Puts Rare Disease Day on the Radar

Dr. Virginia A. Stallings Discusses Individualized Nutrition Therapy for People with Cystic Fibrosis  

See more here

By


Wellsheet Featured in KLAS Spotlight Targeting Physician Burnout

100% of Respondents Would Buy Wellsheet Again for Quick Access to Relevant Electronic Health Record Data to Reduce Time in the EHR 

See more here